HS-20122

DRUG2 trials

Sponsors

Hansoh BioMedical R&D Company, Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorsLung Cancer

Phase 1

A Study of HS-20122 in Patients With Advanced Solid Tumors

RecruitingNCT06927570

Hansoh BioMedical R&D CompanyAdvanced Solid Tumors

Start: 2025-04-15End: 2028-06-30Target: 1050Updated: 2026-01-16

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Not yet recruitingNCT07414953

Jiangsu Hansoh Pharmaceutical Co., Ltd.Lung Cancer

Start: 2026-03-30End: 2028-11-30Target: 400Updated: 2026-02-17